Skip to content
Parakho

Tatva Chintan Pharma Chem Ltd

NSE TATVABSE 543321tatvachintan.com

Q2 FY27, unaudited

Revenue
₹217.32 Cr
Profit after tax
₹21.45 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ2 FY27vs a year ago6M FY27
Revenue from operations217.32+75.94%384.38
Other income1.75+74.01%4.53
Total income219.07+75.93%388.91
Employee benefit expense18.23+21.96%34.97
Finance costs2.71+434.32%4.79
Depreciation & amortisation10.79+19.23%21.36
Total expenses190.13+71.51%337.54
Profit before tax28.94+111.81%50.05
Tax expense7.49+99.92%12.62
Profit after tax21.45+116.31%37.43
Total comprehensive income21.91+105.86%37.57
Earnings per share
Earnings per share, basic₹9.17₹16.00
Earnings per share, diluted₹9.17₹16.00

Q2 FY27 and 6M FY27 — unaudited, from the company’s filing with NSE. Source

Q2 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

Q2 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Tatva Chintan reported Q1 FY27 operating revenue of INR1,671 million, up 43% year-on-year and 25% sequentially, with EBITDA of INR323 million, up 86% year-on-year. Management highlighted growth across Phase Transfer Catalysts, Pharma & Agro Intermediates, and Structure Directing Agents segments, along with the first commercial-scale semiconductor product batch being qualified by a customer. The Board approved a new greenfield manufacturing facility involving an investment of approximately INR200 crores.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Commodities › Chemicals › Specialty Chemicals

Classification as published by BSE.

Companies also in Specialty Chemicals, in alphabetical order

All 112 companies in Specialty Chemicals

Page generated from filings held to 12 Oct 2026.

Tatva Chintan Pharma Chem Ltd (TATVA) Q2 FY27 results — revenue, profit and filings · Parakho